19/02/2024 - General information
The Ministry of Science, Innovation and Universities and the European Union, through the Next Generation EU program will finance this new phase. It will evaluate the efficacy of CTH120 as an innovative therapy in adult patients with SXF, the most common form of hereditary intellectual disability without specific treatment. The public-private consortium formed by the biotechnology company CONNECTA Therapeutics, the Hospital del Mar Research Institute, the Center for Genomic Regulation (CRG), and the Parc Taulí Research and Innovation Institute (I3PT) will receive 2,7 million euros in funding from the Ministry of Science, Innovation and Universities and the European Union, through the Next Generation EU program, to initiate Phase IIa clinical trials of the drug CTH120 for the treatment of Fragile X syndrome (Fragile X syndrome).
Més informació "Nearly 3 million euros to initiate Phase IIa of CTH120 drug for Fragile X syndrome"
23/03/2023 - General information
The Associació Catalana de Gestors Esportius Professionals has recognized the international projection of the Laboratory. The Associació Catalana de Gestors Esportius Professionals (ACGEP) has awarded the Catalonia Prize for Sports Management on a national or international level to the Catalonian Anti-Doping Laboratory of the Hospital del Mar Medical Research Institute. The award recognizes the role of the Laboratory in projecting Catalonia to the world, its professionalism and its contribution to a cleaner sport. It was also highlighted that it is one of the thirty laboratories accredited in the world by the World Anti-Doping Agency to carry out doping controls on athletes, and that it works for clean sport in various national and international events.
18/01/2023 - General information
The Integrated Pharmacology and Systems Neurosciences Research Group of the Hospital del Mar Medical Research Institute has just published a study in Neurobiology of Disease, in which it highlights the role of the CDK5 protein as a possible marker of early psychosis. Furthermore, this protein is modulated by cannabis use. This paves the way for possible future treatments based on CDK5 expression.
Més informació "Possible biomarker for early psychosis identified"
20/12/2022 - General information
The Board of Trustees of the Spanish Psychiatry and Mental Health Foundation has chosen Dr. Víctor Pérez, head of the Psychiatry Department of the Hospital del Mar and coordinator of the Mental Health Research Group of the Hospital del Mar Medical Research Institute, as the new president of the organization. This appointment comes after Dr. Perez left his position as president of the executive committee of the Spanish Society of Psychiatry and Mental Health. As the highest representative of the foundation, Dr. Pérez will be responsible for representing the entity, chairing the meetings of its board of trustees and executing the agreements reached. The aim of its activity is to contribute to the knowledge, development and improvement of psychiatry and mental health and the disciplines that are linked to it.
Més informació "Dr. Víctor Pérez will chair the Spanish Foundation of Psychiatry and Mental Health."
02/11/2022 - General information
The researcher of the Neuroscience Research Program at the Hospital del Mar Medical Research Institute talks in this book with Montserrat Pedreira, PhD in Education and Early Childhood Education teacher, about how we communicate, what makes us curious and how we explore the world. Beatriz Fagundo, PhD in Neuroscience and researcher at the Neuroscience Research Program at IMIM-Hospital del Mar, is one of the authors of Diàlegs entre educació i neurociència, a book that explores the common ground between Neuroscience and Education through a dialogue between the researcher and Montserrat Pedreira, PhD in Education and Early Childhood and Primary Education teacher. The book is published by Eumo Editorial.
Més informació "Diàlegs entre educació i neurociència, the new book of Beatriz Fagundo"
24/10/2022 - General information
The principal investigator of the Research Group on Cell-type mechanisms in normal and pathological behavior at the Hospital del Mar Medical Research Institute received this award at the IACM congress held in Switzerland. Every two years, the International Association for Cannabinoid Medicines (IACM) awards different categories of prizes to researchers working in the field of cannabinoids. This year, the selection committee of this international association has decided to award the Young Investigator Award for research in the field of cannabinoids to Dr. Arnau Busquets, principal investigator of the Research Group on Cell-type mechanisms in normal and pathological behavior at the Hospital del Mar Medical Research Institute (IMIM).
Més informació "IACM Young Investigator Award for Dr. Arnau Busquets"
26/07/2022 - General information
This is the question that Dr. Daniel Guinart, Dr. Víctor Pérez and Dr. Benedikt Amann, researchers from the Neurosciences Research Programme at the Hospital del Mar Medical Research Institute, attempt to answer in a letter recently published in The Lancet. The role peer reviewers of scientific articles play and the debate on whether their work should be remunerated are the focus of a letter by Dr. Daniel Guinart, Dr. Víctor Pérez and Dr. Benedikt Amann, researchers from the Hospital del Mar Medical Research Institute's Neurosciences Research Programme (IMIM-Hospital del Mar) that has been published in The Lancet. It is a voluntary task, based on a "code of honour", as the authors put it, but which in recent times has become an exploitative system.
Més informació "Should reviewers of scientific journal articles be paid a wage?"
14/07/2022 - General information
After the success of "La mare de la ciència", the PRBB's science outreach podcast in Catalan, June saw the launch of "Absolutos y Relativos", the second science outreach podcast from the PRBB, which this time will be in Spanish. On 14 July, Patricia Robledo, a researcher from the Integrated Pharmacology and Systems Neuroscience research group at the IMIM, explains the neuroscience and drug studies she is carrying out, and talks about her research career, which is closely linked to psychology.
13/05/2022 - General information
A platform developed by the Centre Nacional d'Anàlisi Genòmica (CNAG-CRG) allows doctors and researchers from Catalan hospitals to share data and otherwise scattered expertise and diagnose patients with neurologic rare diseases. During the pilot project, a diagnosis was provided to 67 out of 323 patients (20.7% of cases), just by reanalysing previously available data. The results constitute an important milestone for ending the 'diagnostic odyssey' faced by patients in Catalonia. The collaborative approach also resulted in the identification of six new genes linked to specific diseases, which will make it easier to diagnose certain diseases in the future. The results, published today in The Journal of Molecular Diagnostics, were possible thanks to the Undiagnosed Rare Disease Program of Catalonia (URD-Cat), funded by the Departament de Salut de la Generalitat de Catalunya. The URD-Cat project was coordinated by the Hospital del Mar Medical Research Institute (IMIM-Hospital del Mar) and involved more than 140 professionals from 15 different research centres and hospitals.
Més informació "Catalan collaboration helps end ‘diagnostic odyssey’ for rare disease patients"
19/04/2022 - General information
The VALAWAI project, led by the CSIC with the participation of the Hospital del Mar Medical Research Institute and the Hospital del Mar, has received nearly four million euros from the European Innovation Council under the Pathfinder Challenges. A team from the Neuroimaging of Mental Disorders Research Group at the Hospital del Mar Medical Research Institute, led by Dr. Òscar Vilarroya, along with the Innovation Directorate of the Hospital del Mar, headed by Dr. Jordi Martínez, is part of the VALAWAI project (Value-Aware Artificial Intelligence). The project has recently been granted European funding of nearly four million euros. Its objective is to develop a set of tools for creating artificial intelligence systems that incorporate mechanisms sensitive to human values. In other words, these systems should be capable of deciding whether certain actions are morally acceptable and be aware of their users' value systems.
© Institut Hospital del Mar
d'Investigacions MèdiquesLegal Notice and Privacy Policy | Cookie Policy | Site Index | Accessibility | Find Us | Contact